During the past decade, Chambersburg Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 7 clinical trials were completed, i.e. on average, 19.4% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 5 clinical trials were completed. i.e. 23.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chambersburg Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored, "Amgen" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chambersburg Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Chambersburg Hospital" are "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials), "Stage IVB Lung Cancer AJCC v8" (4 trials), "Breast Carcinoma" (3 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "Chambersburg Hospital" in a lesser frequency.

Most popular intervention types in "Chambersburg Hospital" are "Drug" (29 trials), "Other" (19 trials), "Biological" (15 trials), "Procedure" (14 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (11 trials), "Computed Tomography" (11 trials), "Quality-of-Life Assessment" (8 trials), "Magnetic Resonance Imaging" (6 trials) and "Pembrolizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Chambersburg Hospital" are 38 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Chambersburg Hospital". undefined are not yet recruiting, 15 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Chambersburg Hospital, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Chambersburg Hospital, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

Chambersburg Hospital has several departments that took part in Clinical trials: "Cardiac Diagnostic Associates, York Hospital" - 2 trials